Cargando…

Evolution of antibiotic cross‐resistance and collateral sensitivity in Staphylococcus epidermidis using the mutant prevention concentration and the mutant selection window

In bacteria, evolution of resistance to one antibiotic is frequently associated with increased resistance (cross‐resistance) or increased susceptibility (collateral sensitivity) to other antibiotics. Cross‐resistance and collateral sensitivity are typically evaluated at the minimum inhibitory concen...

Descripción completa

Detalles Bibliográficos
Autores principales: Lozano‐Huntelman, Natalie Ann, Singh, Nina, Valencia, Alondra, Mira, Portia, Sakayan, Maral, Boucher, Ian, Tang, Sharon, Brennan, Kelley, Gianvecchio, Crystal, Fitz‐Gibbon, Sorel, Yeh, Pamela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086048/
https://www.ncbi.nlm.nih.gov/pubmed/32211069
http://dx.doi.org/10.1111/eva.12903
_version_ 1783509050848182272
author Lozano‐Huntelman, Natalie Ann
Singh, Nina
Valencia, Alondra
Mira, Portia
Sakayan, Maral
Boucher, Ian
Tang, Sharon
Brennan, Kelley
Gianvecchio, Crystal
Fitz‐Gibbon, Sorel
Yeh, Pamela
author_facet Lozano‐Huntelman, Natalie Ann
Singh, Nina
Valencia, Alondra
Mira, Portia
Sakayan, Maral
Boucher, Ian
Tang, Sharon
Brennan, Kelley
Gianvecchio, Crystal
Fitz‐Gibbon, Sorel
Yeh, Pamela
author_sort Lozano‐Huntelman, Natalie Ann
collection PubMed
description In bacteria, evolution of resistance to one antibiotic is frequently associated with increased resistance (cross‐resistance) or increased susceptibility (collateral sensitivity) to other antibiotics. Cross‐resistance and collateral sensitivity are typically evaluated at the minimum inhibitory concentration (MIC). However, these susceptibility changes are not well characterized with respect to the mutant prevention concentration (MPC), the antibiotic concentration that prevents a single‐step mutation from occurring. We measured the MIC and the MPC for Staphylococcus epidermidis and 14 single‐drug resistant strains against seven antibiotics. We found that the MIC and the MPC were positively correlated but that this correlation weakened if cross‐resistance did not evolve. If any type of resistance did evolve, the range of concentrations between the MIC and the MPC tended to shift right and widen. Similar patterns of cross‐resistance and collateral sensitivity were observed at the MIC and MPC levels, though more symmetry was observed at the MIC level. Whole‐genome sequencing revealed mutations in both known‐target and nontarget genes. Moving forward, examining both the MIC and the MPC may lead to better predictions of evolutionary trajectories in antibiotic‐resistant bacteria.
format Online
Article
Text
id pubmed-7086048
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70860482020-03-24 Evolution of antibiotic cross‐resistance and collateral sensitivity in Staphylococcus epidermidis using the mutant prevention concentration and the mutant selection window Lozano‐Huntelman, Natalie Ann Singh, Nina Valencia, Alondra Mira, Portia Sakayan, Maral Boucher, Ian Tang, Sharon Brennan, Kelley Gianvecchio, Crystal Fitz‐Gibbon, Sorel Yeh, Pamela Evol Appl Original Articles In bacteria, evolution of resistance to one antibiotic is frequently associated with increased resistance (cross‐resistance) or increased susceptibility (collateral sensitivity) to other antibiotics. Cross‐resistance and collateral sensitivity are typically evaluated at the minimum inhibitory concentration (MIC). However, these susceptibility changes are not well characterized with respect to the mutant prevention concentration (MPC), the antibiotic concentration that prevents a single‐step mutation from occurring. We measured the MIC and the MPC for Staphylococcus epidermidis and 14 single‐drug resistant strains against seven antibiotics. We found that the MIC and the MPC were positively correlated but that this correlation weakened if cross‐resistance did not evolve. If any type of resistance did evolve, the range of concentrations between the MIC and the MPC tended to shift right and widen. Similar patterns of cross‐resistance and collateral sensitivity were observed at the MIC and MPC levels, though more symmetry was observed at the MIC level. Whole‐genome sequencing revealed mutations in both known‐target and nontarget genes. Moving forward, examining both the MIC and the MPC may lead to better predictions of evolutionary trajectories in antibiotic‐resistant bacteria. John Wiley and Sons Inc. 2020-02-25 /pmc/articles/PMC7086048/ /pubmed/32211069 http://dx.doi.org/10.1111/eva.12903 Text en © 2019 The Authors. Evolutionary Applications published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Lozano‐Huntelman, Natalie Ann
Singh, Nina
Valencia, Alondra
Mira, Portia
Sakayan, Maral
Boucher, Ian
Tang, Sharon
Brennan, Kelley
Gianvecchio, Crystal
Fitz‐Gibbon, Sorel
Yeh, Pamela
Evolution of antibiotic cross‐resistance and collateral sensitivity in Staphylococcus epidermidis using the mutant prevention concentration and the mutant selection window
title Evolution of antibiotic cross‐resistance and collateral sensitivity in Staphylococcus epidermidis using the mutant prevention concentration and the mutant selection window
title_full Evolution of antibiotic cross‐resistance and collateral sensitivity in Staphylococcus epidermidis using the mutant prevention concentration and the mutant selection window
title_fullStr Evolution of antibiotic cross‐resistance and collateral sensitivity in Staphylococcus epidermidis using the mutant prevention concentration and the mutant selection window
title_full_unstemmed Evolution of antibiotic cross‐resistance and collateral sensitivity in Staphylococcus epidermidis using the mutant prevention concentration and the mutant selection window
title_short Evolution of antibiotic cross‐resistance and collateral sensitivity in Staphylococcus epidermidis using the mutant prevention concentration and the mutant selection window
title_sort evolution of antibiotic cross‐resistance and collateral sensitivity in staphylococcus epidermidis using the mutant prevention concentration and the mutant selection window
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7086048/
https://www.ncbi.nlm.nih.gov/pubmed/32211069
http://dx.doi.org/10.1111/eva.12903
work_keys_str_mv AT lozanohuntelmannatalieann evolutionofantibioticcrossresistanceandcollateralsensitivityinstaphylococcusepidermidisusingthemutantpreventionconcentrationandthemutantselectionwindow
AT singhnina evolutionofantibioticcrossresistanceandcollateralsensitivityinstaphylococcusepidermidisusingthemutantpreventionconcentrationandthemutantselectionwindow
AT valenciaalondra evolutionofantibioticcrossresistanceandcollateralsensitivityinstaphylococcusepidermidisusingthemutantpreventionconcentrationandthemutantselectionwindow
AT miraportia evolutionofantibioticcrossresistanceandcollateralsensitivityinstaphylococcusepidermidisusingthemutantpreventionconcentrationandthemutantselectionwindow
AT sakayanmaral evolutionofantibioticcrossresistanceandcollateralsensitivityinstaphylococcusepidermidisusingthemutantpreventionconcentrationandthemutantselectionwindow
AT boucherian evolutionofantibioticcrossresistanceandcollateralsensitivityinstaphylococcusepidermidisusingthemutantpreventionconcentrationandthemutantselectionwindow
AT tangsharon evolutionofantibioticcrossresistanceandcollateralsensitivityinstaphylococcusepidermidisusingthemutantpreventionconcentrationandthemutantselectionwindow
AT brennankelley evolutionofantibioticcrossresistanceandcollateralsensitivityinstaphylococcusepidermidisusingthemutantpreventionconcentrationandthemutantselectionwindow
AT gianvecchiocrystal evolutionofantibioticcrossresistanceandcollateralsensitivityinstaphylococcusepidermidisusingthemutantpreventionconcentrationandthemutantselectionwindow
AT fitzgibbonsorel evolutionofantibioticcrossresistanceandcollateralsensitivityinstaphylococcusepidermidisusingthemutantpreventionconcentrationandthemutantselectionwindow
AT yehpamela evolutionofantibioticcrossresistanceandcollateralsensitivityinstaphylococcusepidermidisusingthemutantpreventionconcentrationandthemutantselectionwindow